English
全部
搜索
图片
视频
地图
资讯
更多
购物
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
资讯
生物通
2 小时
DDX24:肾癌治疗新希望,靶向调控 AKR1B10 抑制 ccRCC 进展
肾癌(RC)发病率上升,其中透明细胞肾细胞癌(ccRCC)是主要亚型,早期诊断困难且缺乏有效标记物。研究人员探究 DEAD-box 解旋酶 24(DDX24)在 ccRCC 中的作用,发现其能抑制 ccRCC 进展,为 ccRCC 治疗提供潜在靶点。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Funeral set for Saturday
Harvard sues Trump admin
Accused of sexual assault
Cause of death revealed
Lokedi breaks course record
SC Senate removal hearing
FTC files lawsuit
Today in history: 1970
To resume collecting loans
Canonization postponed
RU welcomes US proposal
RI Senate president dies
To hear bias suit appeal
Queens house fire kills 3
Convicted in bribery scheme
Walmart shooter pleads guilty
Hawks fire GM Fields
Running for GA governor
4-yr extension w/ Eagles
To face monopoly trial
CA opioid reversal drug sale
Feds give NY another month
Chairman Schwab retires
To open in Mexico
Kristi Noem’s purse stolen
Delta plane catches fire
Tries AI for age detection
US, Philippines launch drills
Blasts media, ex-employees
Lyrid meteor shower
China sanctions US officials
Returns to SCOTUS
反馈